XELB:NASDAQXcel Brands, Inc Analysis
Data as of 2026-06-07 - not real-time
$2.01
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The stock is trading just above its 20‑day SMA, which remains above the 50‑day SMA, indicating a short‑term bullish bias. However, MACD has turned bearish with the histogram below zero, and RSI hovers near the mid‑range, suggesting limited momentum and potential for a pull‑back.
Fundamental backdrop: Xcel Brands reports a steep revenue decline of roughly 14% YoY, negative operating margins, and a sizable net loss exceeding $2 million. Cash flow is deeply negative and debt vastly outweighs equity, while the PE ratio is negative and the price‑to‑book sits below 1, flagging valuation distress. Liquidity & sentiment: Volume is rising but overall market cap is under $13 million, and the beta of ~1.8 points to heightened price swings. The Fear & Greed Index reads “Extreme Greed,” implying market optimism may be overstated given the company’s financial strain.
Fundamental backdrop: Xcel Brands reports a steep revenue decline of roughly 14% YoY, negative operating margins, and a sizable net loss exceeding $2 million. Cash flow is deeply negative and debt vastly outweighs equity, while the PE ratio is negative and the price‑to‑book sits below 1, flagging valuation distress. Liquidity & sentiment: Volume is rising but overall market cap is under $13 million, and the beta of ~1.8 points to heightened price swings. The Fear & Greed Index reads “Extreme Greed,” implying market optimism may be overstated given the company’s financial strain.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD signal despite price above short‑term SMA
- Negative earnings and cash flow
- Rising volume indicating short‑term interest
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued price‑to‑book ratio
- Access to a $15 million equity line for potential capital infusion
- Potential upside of >140% based on upside/downside metric
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained operating losses and high debt‑to‑equity
- Volatile price behavior (beta ~1.8, 30‑day volatility ~98%)
- Lack of dividend and unclear path to profitability
Key Metrics & Analysis
Financial Health
Revenue Growth-14.10%
P/E Ratio-1.0
ROE-88.78%
ROA-10.11%
Debt/Equity133.12
P/B Ratio0.7
Op. Cash Flow$-6466000
Free Cash Flow$-7944000
Technical Analysis
TrendBullish
RSI46.1
Support$1.84
Resistance$2.38
MA 20$2.13
MA 50$1.99
MA 200$1.56
MACDBearish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
Target Price$5.00
Upside/Downside148.76%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.82
Volatility97.57%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKYOU
Clear Secure, Inc.
STOCKABCL
AbCellera Biologics Inc.
STOCKWETH
Wetouch Technology Inc.
STOCKSOPA
Society Pass Incorporated
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.